11:50 AM EST - Aurinia Pharmaceuticals Inc. : Released its financial results for the year ended December 31, 2016. Amounts, unless specified otherwise, are expressed in U.S. dollars. The Company recorded a consolidated net loss of $23.3 million or $0.66 per common share, as compared to a consolidated net loss of $18.6 million or $0.58 per common share in 2015. Aurinia Pharmaceuticals Inc.
shares T.AUP are trading up $0.51 at $10.23.
